On 2 April 2008, the U.S. House of Representatives passed a bill (H.R. 5501) to reauthorize the President's Emergency Plan for AIDS Relief (PEPFAR). The House bill would authorize the appropriation of US$50 billion over the next five years--40 percent more than the US$30 billion requested by President George W. Bush.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Global fight against HIV is at risk.
Science
November 2023
Myron S. Cohen is the director of the Institute for Global Health and Infectious Diseases and professor of Medicine, Microbiology and Immunology and Epidemiology at the University of North Carolina, Chapel Hill, NC, USA.
Will the United States remain committed to a landmark health program it started 20 years ago that saved more than 25 million lives around the world? For a younger generation of physicians, nurses, and researchers today, the depth of despair wrought by the HIV/AIDS epidemic at that time is almost unimaginable. Even more profoundly, for countries in Africa, the epidemic presented an existential threat. Without access to antiretroviral therapy or efficacious prevention tools, new infections continued unfettered, and people with HIV/ AIDS faced near-certain death.
View Article and Find Full Text PDFPEPFAR Reauthorization by Congress Urgent for Global Health.
JAMA
November 2023
Center for Global Health Delivery, Diplomacy, and Economics, Institute for Global Health, University of California, San Francisco.
Threatening the Global AIDS Response - Obstacles to PEPFAR's Reauthorization.
N Engl J Med
September 2023
From the Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban (S.S.A.K.); the Department of Epidemiology, Mailman School of Public Health, Columbia University (S.S.A.K.), and Weill Cornell Medicine (H.E.V., J.W.P.) - both in New York; Paris (F.B.-S.); Makerere University School of Public Health, Kampala, and Rakai Health Sciences Program, Kalisizo - both in Uganda (D.S.); the Centre for Microbiology Research, Kenya Medical Research Institute, Nairobi (E.B.); the Departments of Global Health and Obstetrics and Gynecology, University of Washington, Seattle (E.B.); the Institut de Recherche en Santé, de Surveillance Epidémiologique et de Formation, and the School of Medicine and Pharmacy, Université Cheikh Anta Diop - both in Dakar, Senegal (S.M.); Monash University Malaysia, Selangor, and the Faculty of Medicine, University of Malaya, Kuala Lumpur - both in Malaysia (A.K.); the M.S. Swaminathan Research Foundation, Chennai, India (S.S.); and Les Centres GHESKIO, Port-au-Prince, Haiti (J.W.P.).
The Reauthorization Of PEPFAR To 2023.
Health Aff (Millwood)
March 2019
Tom Kenyon is CEO and chief medical officer of Project HOPE, in Millwood, Virginia. From 2006 to 2008 he served as principal deputy global AIDS coordinator and chief medical officer for PEPFAR.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!